All stock lists
Roivant Sciences Ltd. (NASDAQ:ROIV)
GB · Delayed Price · Currency is USD
36.49-0.96 (-2.56%)
Insider Score
––Not scored
ROIV Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
ROIV Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 1.44 M | 2.52 M | 2.00 M | 1.57 M | 2.17 M | 7.57 M |
| Revenue Growth (YoY) | -33.55 % | -66.71 % | -77.83 % | -64.89 % | -72.84 % | -73.83 % |
| Cost of Revenue | 284.00 K | 320.00 K | 700.00 K | 111.00 K | 154.00 K | 205.00 K |
| Gross Profit | 1.16 M | 2.20 M | 1.30 M | 1.46 M | 2.02 M | 7.37 M |
| SG&A Expense | 165.53 M | 158.25 M | 175.07 M | 143.13 M | 134.02 M | 147.09 M |
| R&D Expense | 202.02 M | 198.94 M | 165.38 M | 164.57 M | 152.92 M | 145.24 M |
| Operating Expenses | 367.15 M | 357.19 M | 340.45 M | 307.69 M | 286.94 M | 292.33 M |
| Operating Income | -365.99 M | -355.00 M | -339.15 M | -306.23 M | -284.92 M | -284.96 M |
| Pretax Income | -294.56 M | 454.10 M | -290.37 M | -159.04 M | -269.26 M | -203.05 M |
| Tax Provision | -3.96 M | 98.35 M | 23.33 M | 7.00 M | 4.65 M | 49.32 M |
| Net Income | -189.83 M | 302.99 M | -265.89 M | -113.52 M | -223.35 M | -206.47 M |
| EPS (Basic) | -0.26 | 0.43 | -0.38 | -0.17 | -0.33 | -0.29 |
| EPS (Diluted) | -0.26 | 0.37 | -0.38 | -0.17 | -0.33 | -0.29 |
| Shares Outstanding | 720.78 M | 702.13 M | 696.86 M | 680.95 M | 680.29 M | 707.30 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.